Coeptis Therapeutics Holdings's total assets for Q3 2024 were $8.96M, a decrease of -23.77% from the previous quarter. COEP total liabilities were $3.97M for the fiscal quarter, a -11.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.